Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
SHANGHAI PECHEM
00338
5
SINOPEC CORP
00386
| (FY)Dec 31, 2025 | (Q4)Dec 31, 2025 | (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow (Indirect Method) | ||||||||||
| Cash from operating activities | -81.30%17.76M | -72.86%14.16M | -79.77%5.37M | 204.58%8.62M | -142.45%-10.4M | -19.67%94.95M | -13.46%52.18M | -40.49%26.53M | -130.60%-8.25M | 279.71%24.49M |
| Net profit before non-cash adjustment | -48.69%43.54M | -82.20%7.24M | 212.94%24.72M | -105.95%-1.75M | -63.65%13.32M | -41.27%84.84M | 9.07%40.67M | -135.78%-21.89M | -12.35%29.42M | 194.95%36.65M |
| Total adjustment of non-cash items | 138.02%4.82M | 115.72%5.5M | -120.66%-7.65M | 317.18%8.29M | 87.83%-1.33M | 57.89%-12.68M | -147.11%-34.96M | 359.01%37.01M | -342.32%-3.82M | -236.11%-10.9M |
| -Depreciation and amortization | -1.63%9.32M | ---- | ---- | ---- | ---- | -16.97%9.47M | ---- | ---- | ---- | ---- |
| -Reversal of impairment losses recognized in profit and loss | 12,341.43%2.42M | ---- | ---- | ---- | ---- | -105.18%-19.8K | ---- | ---- | ---- | ---- |
| -Disposal profit | -52.06%-16.62M | ---- | ---- | ---- | ---- | 70.58%-10.93M | ---- | ---- | ---- | ---- |
| -Net exchange gains and losses | 641.56%12.95M | ---- | ---- | ---- | ---- | -444.60%-2.39M | ---- | ---- | ---- | ---- |
| -Remuneration paid in stock | --2.22M | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| -Other non-cash items | 37.83%-5.47M | ---- | ---- | ---- | ---- | -62.29%-8.8M | ---- | ---- | ---- | ---- |
| Changes in working capital | -234.30%-30.6M | -96.93%1.43M | -202.58%-11.71M | 106.14%2.08M | -1,674.41%-22.39M | 492.91%22.78M | 25.08%46.47M | 593.77%11.42M | -313.31%-33.84M | 94.47%-1.26M |
| -Change in receivables | -105.13%-2.81M | ---- | ---- | ---- | ---- | 1,942.74%54.73M | ---- | ---- | ---- | ---- |
| -Change in inventory | -105.03%-276.71K | ---- | ---- | ---- | ---- | -48.14%5.5M | ---- | ---- | ---- | ---- |
| -Change in payables | 26.55%-27.51M | ---- | ---- | ---- | ---- | -886.64%-37.45M | ---- | ---- | ---- | ---- |
| Dividends paid (cash flow from operating activities) | ||||||||||
| Dividends received (cash flow from operating activities) | ||||||||||
| Interest paid (cash flow from operating activities) | ||||||||||
| Interest received (cash flow from operating activities) | ||||||||||
| Tax refund paid | 64.29%-8.66M | 87.74%-955.53K | 90.07%-754K | 20.89%-4.11M | 22.43%-2.84M | 8.25%-24.24M | -145.34%-7.79M | 4.94%-7.59M | 27.77%-5.19M | 54.62%-3.66M |
| Other operating cash inflow (outflow) | 0 | -18.18%27K | 40.00%-3K | -400.00%-5K | 29.63%-19K | 0 | 3.13%33K | 16.67%-5K | 80.00%-1K | -28.57%-27K |
| Operating cash flow | -87.13%9.1M | -70.20%13.23M | -75.64%4.61M | 133.59%4.51M | -163.72%-13.26M | -22.95%70.71M | -22.28%44.41M | -48.26%18.93M | -168.01%-13.44M | 195.79%20.8M |
| Investing cash flow | ||||||||||
| Net PPE purchase and sale | 52.47%-2.87M | -203.04%-9.02M | 1,587.17%7.88M | 103.78%81K | -364.45%-1.82M | -147.55%-6.04M | -197.84%-2.98M | -103.60%-530K | -1,483.23%-2.14M | 67.12%-391K |
| Net business purchase and sale | ---- | ---- | ---- | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| Net investment product transactions | -9.75%9.8M | ---- | ---- | ---- | ---- | 12.47%10.86M | ---- | ---- | ---- | ---- |
| Dividends received (cash flow from investment activities) | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Interest received (cash flow from investment activities) | -37.72%5.5M | -31.06%-6.11M | 34.21%4.18M | -31.40%3.31M | -25.86%4.11M | 61.77%8.83M | 10.81%-4.66M | -16.24%3.12M | 34.66%4.83M | 64.18%5.55M |
| Net changes in other investments | --9M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Investing cash flow | 57.00%21.43M | 13.98%3.68M | 366.51%12.06M | 26.48%3.39M | -55.46%2.3M | -74.34%13.65M | -90.49%3.23M | -85.99%2.59M | 292.60%2.68M | 135.50%5.16M |
| Financing cash flow | ||||||||||
| Net common stock issuance | 413.83%13.82M | 22,912.63%13.8M | -101.15%-1K | --0 | -99.23%16K | 216.58%2.69M | -76.88%59.98K | --87K | 110.95%476K | 15.94%2.07M |
| Increase or decrease of lease financing | 8.40%-962.02K | 2.17%-238.02K | 7.66%-241K | 10.07%-241K | 12.95%-242K | 21.66%-1.05M | 20.13%-243.29K | 20.67%-261K | 22.77%-268K | 22.78%-278K |
| Cash dividends paid | 21.70%-46.13M | -229.80%-331 | --0 | --0 | ---46.13M | -9.18%-58.91M | 21.43%255 | --0 | ---- | ---- |
| Financing cash flow | 41.91%-33.27M | 7,509.30%13.56M | -39.08%-242K | 99.59%-241K | -2,692.56%-46.36M | 0.58%-57.28M | -306.83%-183.06K | 47.11%-174K | -0.08%-58.71M | 25.74%1.79M |
| Net cash flow | ||||||||||
| Beginning cash position | 6.29%478.97M | 7.01%437.69M | 0.70%420.45M | -13.37%420.83M | 6.29%478.97M | 24.60%450.64M | 12.90%409.03M | 37.14%417.51M | 40.93%485.79M | 24.55%450.64M |
| Current changes in cash | -110.12%-2.74M | -35.78%30.48M | -23.01%16.43M | 111.03%7.66M | -306.58%-57.31M | -69.00%27.08M | -47.87%47.46M | -60.99%21.34M | -72.39%-69.46M | 253.25%27.74M |
| Effect of exchange rate changes | -1,069.50%-12.07M | -117.83%-4.01M | 102.70%806K | -777.84%-8.05M | -111.06%-819K | -23.19%1.24M | 984.55%22.47M | -1,053.93%-29.82M | 2,537.78%1.19M | 647.88%7.4M |
| End cash Position | -3.09%464.16M | -3.09%464.16M | 7.01%437.69M | 0.70%420.45M | -13.37%420.83M | 6.29%478.97M | 6.29%478.97M | 12.90%409.03M | 37.14%417.51M | 40.93%485.79M |
| Free cash flow | -90.42%6.19M | -68.44%13.08M | -80.23%3.63M | 129.45%4.59M | -174.07%-15.11M | -27.35%64.6M | -26.21%41.44M | -48.95%18.36M | -179.20%-15.6M | 189.07%20.4M |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.